EW Edwards Lifesciences
Permanent stock page ↗Health Care · S&P 500
Next earnings: not announced yet
What 28 analyst firms say about Edwards Lifesciences: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
27 rated views · 29 analyst/firm records · 28 firms
Radar score
- S&P 500 · Top Picks · 6MNot scored · Average target is not above the current price
- S&P 500 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 29 reports on EW from 18 analyst firms in the last 90 days (28 firms in the past year).
Comparing each firm's latest target with its previous one: 13 raised their price target, 1 lowered it and 2 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: BTIG Research raised its target from $110.00 (set 11 Sep 2026) to $115.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | Buy | 20 Aug 2026 | 115.00 USD |
| Baird | David Rescott | Hold | 15 Oct 2026 | 90.00 USD |
| Barclays | Christopher Pasquale | Buy | 7 Oct 2026 | 110.00 USD |
| Bernstein | Lee Hambright | Hold | 24 Jul 2026 | 99.00 USD |
| BTIG | Marie Thibault | Buy | 11 Sep 2026 | 110.00 USD |
| Canaccord Genuity | William J Plovanic | Hold | 2 Aug 2026 | 85.00 USD |
| Citigroup | Joanne Wuensch | Buy | 5 Oct 2026 | 101.00 USD |
| Daiwa | Narumi Nakagiri | Buy | 15 Sep 2026 | 98.00 USD |
| DBS | Nico Chen | Hold | 1 Jul 2026 | 81.00 USD |
| Deutsche Bank | Unnamed analyst | — | 27 Oct 2026 | 104.00 USD |
| Evercore ISI | Vijay Kumar | Buy | 23 Oct 2026 | 102.00 USD · 5 Oct 2026 |
| Goldman Sachs | David H Roman | Buy | 14 Jul 2026 | 102.00 USD |
| Jefferies | Matthew C Taylor | Buy | 27 May 2026 | 105.00 USD |
| JPMorgan | Robbie Marcus | Buy | 2 Oct 2026 | 105.00 USD |
| Leerink Partners | Mike Kratky | Buy | 24 Jul 2026 | 101.00 USD |
| Mizuho | Anthony Petrone | Buy | 15 Jul 2026 | 105.00 USD |
| Piper Sandler | Adam Maeder | Buy | 24 Jul 2026 | 101.00 USD |
| Raymond James | Jayson T Bedford | Buy | 23 Jul 2026 | — |
| RBC Capital Markets | Kendall Au | Buy | 23 Jul 2026 | 110.00 USD |
| RBC Capital Markets | Shagun Singh | Buy | 13 Jul 2026 | 110.00 USD |
| Redburn | Ed Ridley-Day | Buy | 27 Jul 2026 | 102.00 USD |
| Stifel | Rick Wise | Buy | 20 Jan 2026 | 110.00 USD |
| TD Cowen | Joshua Jennings | Buy | 27 Oct 2026 | Conflicting reports · excluded |
| Truist | Richard Newitter | Hold | 16 Jul 2026 | 95.00 USD |
| UBS | Patrick Wood | Buy | 8 Oct 2026 | 110.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Lawrence H Biegelsen | Buy | 11 Aug 2026 | 100.00 USD |
| Wolfe Research | Mike Polark | Buy | 24 Jul 2026 | 100.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 93.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:24 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.